Journal of Chronotherapy and Drug Delivery uses online peer review to speed up the publication process. The time taken to reach a final decision depends on whether reviewers request revisions, and how quickly authors are able to respond. Once an article is accepted, it will be published in the journal. The ultimate responsibility for any decision lies with the Editor-in-Chief, to whom any appeals against rejection should be addressed.
All the material submitted for publication is subject to editorial review and revision. Only unpublished material will be considered for publication. Material submitted to the journal must not be under consideration for publication elsewhere. The authors have to provide a declaration regarding this and should be signed by the all the authors.
Authors should submit their complete manuscript (title page, abstract, text, references, tables and figures) as Microsoft Word document. Tables and Figures should be embedded in the text document at the end of the manuscript with proper labeling. Authors should submit their contributions by e-mail to Editor-in-Chief (email@example.com).
While making a contribution, the authors are requested to ensure that the following documents are submitted:
Cover Letter indicating the name, postal address, telephone and fax numbers, and e-mail address to which correspondence and proofs are to be sent.
- Manuscript of the article / paper
- Figures / Drawings / Graphs, either embedded in the text document or as separate files (only .jpg, .png, .xl, .xls files are accepted)
- Open Access Copyright Agreement, duly filled, signed and scanned as .jpg, .png or .pdf
All manuscripts will be acknowledged by e-mail upon receipt, and all the communications will be made via e-mail, by the Editor-in-Chief.
Ethical and Disclosure Matters
Authors are required to conduct their research ethically and according to the principles and standards of their affiliated academic or other institutions and as required by the journal. The authors are expected to clearly state in the Methods section the study has been approved by the local sanctioning board and that it meets the ethical standards of the journal by citing the aforementioned publication. Authors are also required to report financial as well as formal and informal relationships of the research sponsor. (For more details, please refer to ‘Publication Ethics’ section.
Journal of Chronotherapy and Drug Delivery is an open access journal. Hence, the authors have to accept the terms and conditions under Creative Commons license. No paper will be published until transfer of copyright forms are executed and submitted to the publisher. Transfer of copyright forms will be given to the correspondent author after acceptance of the papers. Duly filled and signed forms must be submitted to the Editor-in-Chief by post or as scanned copy by e-mail.
Journal of Chronotherapy and Drug Delivery follows double blind peer review process. The authors as well as the reviewers remain anonymous. Immediately after receiving the paper, a manuscript number is allotted and then, the paper will be sent to peer reviewing, which may be done by any of the editorial board / advisory board members. The paper will be accepted for publication only if at least two reviewers accept it for publication. To reduce the time duration, the journal sends the paper to the reviewers by email and requests them to submit the report within a period of 15 days.
Page proofs are sent to the correspondent author by e-mail. They must be carefully checked and returned by e-mail within 4 days of receipt, along with a MS Word file in which the corrections are mentioned. If there number of corrections is more than five, the publication of the paper will be rescheduled. After publication, the author for correspondence will receive a pdf file of the article by e-mail.
Since Journal of Chronotherapy and Drug Delivery is an open access online journal, the article processing charges are to be borne by the authors. Currently, the charges are INR 1500.00 or USD 25.00 per paper.